A recent study addressing the increased risk of AD in patients affected by rheumatoid arthritis (RA) indicates that RA patients treated with anti-TNFα therapy for RA showed a reduced risk to develop AD (64). The gene discussed is TNF; the disease is Alzheimer disease.